Using the new antiepilepsy drugs in children

Journal of Child Neurology

Volumn 17, Issue SUPPL. 1, 2002, Pages

  Wheless, James W ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CARBONATE DEHYDRATASE INHIBITOR; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; ORAL CONTRACEPTIVE AGENT; OXCARBAZEPINE; PENTETRAZOLE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; PYRIDOXINE; SULFONAMIDE; VALPROIC ACID; ZONISAMIDE;

ANTICONVULSANT ACTIVITY; ANTICONVULSANT THERAPY; AREA UNDER THE CURVE; ARTICLE; CHILD; CHILDHOOD DISEASE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG ABSORPTION; DRUG ACETYLATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CAPSULE; DRUG CLEARANCE; DRUG EFFICACY; DRUG ELIMINATION; DRUG EXCRETION; DRUG HALF LIFE; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG SAFETY; DRUG SCREENING; DRUG SOLUBILITY; DRUG STABILITY; EPILEPSY; HUMAN; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SEIZURE; UNITED STATES;

EID: 0036238941     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738020170010801     Document Type: Article

References (43)

1. The pharmacologic basis of antiepileptic drug action
2. Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs
3. Antiepileptic drug pharmacokinetics and interactions: Impact on treatment of epilepsy
4. Antiepileptic drug interactions
5. Pharmacokinetic properties of current antiepileptic drugs. What improvements are needed?
6. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy
7. Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy
8. Pharmacokinetic profile of levetiracetam: Toward ideal characteristics
9. Levetiracetam. A review of its adjunctive use in the management of partial onset seizures
10. An assessment of levetiracetam as an anti-epileptic drug
11. Single dose pharmacokinetics of levetiracetam in pediatric patients with partial epilepsy
12. Oxcarbazepine: A review
13. Oxcarbazepine: Mechanisms of action
14. Adjunctive therapy with oxcarbazepine in children with partial seizures
15. Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy
16. Safety and efficacy of oxcarbazepine monotherapy in patients with uncontrolled partial-onset seizures: A multicenter, double-blind, randomized, parallel-group trial
17. Clinical pharmacology and pharmacokinetics of oxcarbazepine
18. Oxcarbazepine
19. Oxcarbazepine: Current status and clinical applications
20. Oxcarbazepine: Pharmacokinetic interactions and their clinical relevance
21. Induction of ethinylestradiol and levonorgestral metabolism by oxcarbazepine in healthy women
22. Possible interaction between oxcarbazepine and an oral contraceptive
23. Oxcarbazepine in the treatment of early childhood epilepsy
24. Comparison of oxcarbazepine and carbamazepine: A double-blind study
25. A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy
26. Zonisamide
27. Clinical pharmacology and therapeutic drug monitoring of zonisamide
28. Zonisamide: A new antiepileptic drug
29. Zonisamide in pediatric epilepsy: A review of the Japanese experience
30. Effects of zonisamide on dopaminergic system
31. Steady-state pharmacokinetics of zonisamide, an antiepileptic agent for treatment of refractory complex partial seizures
32. Open clinical trial of a new antiepileptic drug, zonisamide (ZNA), on 49 patients with refractory epileptic seizures
33. Review of U.S. clinical trials of zonisamide in treatment of refractory partial-onset seizures
34. Monotherapy for childhood epilepsies with zonisamide
35. Efficacy and safety of zonisamide in pediatric epilepsy: The Japanese experience
36. Safety of zonisamide in Japanese children
37. Zonisamide dosing in pediatric patients with epilepsy
38. Zonisamide treatment of early infantile epileptic encephalopathy
39. Successful zonisamide treatment for infants with hypsarrhythmia
40. Treatment of infantile spasms with zonisamide
41. Zonisamide monotherapy in newly diagnosed infantile spasms
42. Controversies in blood-level monitoring: Reexamining its role in the treatment of epilepsy